Treatment impact on estimated medical expenditure and job loss likelihood in rheumatoid arthritis: re-examining quality of life outcomes from a randomized placebo-controlled clinical trial with abatacept

scientific article published on 17 May 2008

Treatment impact on estimated medical expenditure and job loss likelihood in rheumatoid arthritis: re-examining quality of life outcomes from a randomized placebo-controlled clinical trial with abatacept is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/RHEUMATOLOGY/KEN141
P698PubMed publication ID18487628
P5875ResearchGate publication ID5362102

P2093author name stringT Li
P Lin
R MacLean
J C Cole
G V Wallenstein
P433issue7
P921main subjectrheumatoid arthritisQ187255
placeboQ269829
P304page(s)1044-1050
P577publication date2008-05-17
P1433published inRheumatologyQ7320492
P1476titleTreatment impact on estimated medical expenditure and job loss likelihood in rheumatoid arthritis: re-examining quality of life outcomes from a randomized placebo-controlled clinical trial with abatacept
P478volume47

Reverse relations

cites work (P2860)
Q24240131Abatacept for rheumatoid arthritis
Q36032715Decision tool to improve the quality of care in rheumatoid arthritis
Q38689012Estimated medical expenditure and risk of job loss among rheumatoid arthritis patients undergoing tofacitinib treatment: post hoc analyses of two randomized clinical trials
Q36931485Investigating the value of abatacept in the treatment of rheumatoid arthritis: a systematic review of cost-effectiveness studies
Q37682875Newer biological agents in rheumatoid arthritis: impact on health-related quality of life and productivity
Q37633537Therapeutic agents for patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor-alpha antagonists

Search more.